Residential College | false |
Status | 已發表Published |
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts | |
Shu,Ting1,2; Huang,Muhan2; Wu,Di2; Ren,Yujie2,3; Zhang,Xueyi2; Han,Yang1,2; Mu,Jingfang2; Wang,Ruibing4; Qiu,Yang1,2,5; Zhang,Ding Yu1; Zhou,Xi1,2,5 | |
2020-06-01 | |
Source Publication | Virologica Sinica |
ISSN | 1674-0769 |
Volume | 35Issue:3Pages:321-329 |
Abstract | The ongoing outbreak of Coronavirus Disease 2019 (COVID-19) has become a global public health emergency. SARS-coronavirus-2 (SARS-CoV-2), the causative pathogen of COVID-19, is a positive-sense single-stranded RNA virus belonging to the family Coronaviridae. For RNA viruses, virus-encoded RNA helicases have long been recognized to play pivotal roles during viral life cycles by facilitating the correct folding and replication of viral RNAs. Here, our studies show that SARS-CoV-2-encoded nonstructural protein 13 (nsp13) possesses the nucleoside triphosphate hydrolase (NTPase) and RNA helicase activities that can hydrolyze all types of NTPs and unwind RNA helices dependently of the presence of NTP, and further characterize the biochemical characteristics of these two enzymatic activities associated with SARS-CoV-2 nsp13. Moreover, we found that some bismuth salts could effectively inhibit both the NTPase and RNA helicase activities of SARS-CoV-2 nsp13 in a dose-dependent manner. Thus, our findings demonstrate the NTPase and helicase activities of SARS-CoV-2 nsp13, which may play an important role in SARS-CoV-2 replication and serve as a target for antivirals. |
Keyword | Antiviral Target Helicase Nsp13 Ntpase Sars-coronavirus-2 (Sars-cov-2) |
DOI | 10.1007/s12250-020-00242-1 |
URL | View the original |
Indexed By | SCIE |
WOS Research Area | Virology |
WOS Subject | Virology |
WOS ID | WOS:000537953600001 |
Scopus ID | 2-s2.0-85085988704 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | DEPARTMENT OF PHARMACEUTICAL SCIENCES Institute of Chinese Medical Sciences THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) |
Corresponding Author | Zhang,Ding Yu; Zhou,Xi |
Affiliation | 1.Center for Translational Medicine,Wuhan Jinyintan Hospital,Wuhan,430023,China 2.State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China 3.Center for Precision Translational Medicine of Wuhan Institute of Virology and Guangzhou Women and Children’s Medical Center,Guangzhou Women and Children’s Medical Center,Guangzhou,510120,China 4.State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau SAR,999078,China 5.University of Chinese Academy of Sciences,Beijing,100049,China |
Recommended Citation GB/T 7714 | Shu,Ting,Huang,Muhan,Wu,Di,et al. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts[J]. Virologica Sinica, 2020, 35(3), 321-329. |
APA | Shu,Ting., Huang,Muhan., Wu,Di., Ren,Yujie., Zhang,Xueyi., Han,Yang., Mu,Jingfang., Wang,Ruibing., Qiu,Yang., Zhang,Ding Yu., & Zhou,Xi (2020). SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts. Virologica Sinica, 35(3), 321-329. |
MLA | Shu,Ting,et al."SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts".Virologica Sinica 35.3(2020):321-329. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment